510(k) Report

510(k) · Cleared

Cleared

Lifeguard

K022755510(k) TraditionalCleared Sep 24, 200235-day reviewClass II21 CFR 864.6550

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medtek, LLC · KHE Reagent, Occult Blood

Cleared on Sep 24, 2002 after a 35-day review. FDA’s file for it is a 510(k) statement, which names no predicate.

Decided
Sep 24, 2002
Review
35 days
Class
Class II
Product code
KHE
Recalls
None
Predicates
0

FDA’s file for it is a 510(k) statement, which names no predicate.

FIG. 1 — Lineage of K022755Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KHE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All KHE devices

KHE Reagent, Occult Blood: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · KHE

1in 2018

2007: 32008: 32010: 22011: 22012: 22015: 12017: 42018: 1
2007high 4 (2017) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KHE

126in 2017

2007: 104 days median2008: 93 days median2017: 126 days median
2007high 126 (2017) · low 93 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KHE

2in 2025

2008: 12011: 62013: 22018: 12020: 12025: 2
2007high 6 (2011) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KHE

3in 2025

2007: 32008: 52009: 52010: 42011: 42012: 32013: 162014: 62015: 102016: 32017: 12018: 12019: 12020: 12021: 22023: 12024: 22025: 3
2007high 16 (2013) · low 0 (2022)2025

MAUDE reports naming product code KHE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007310403
200839315
20090—05
20102—04
20112—64
20122—03
20130—216
20140—06
20151—010
20160—03
2017412601
20181—11
20190—01
20200—11
20210—02
20220—00
20230—01
20240—02
20250—23
20260—0—

What is it indicated for?

The LifeGuardTM is a guaiac-based test for the qualitative detection of occult blood in stool, which may indicate gastrointestinal disease. Patients can purchase the test without a prescription from stores or Internet distributors in order to perform testing at home. Users obtain their own stool samples by wiping onto the test device, then develop the tests, read the test results, and send a report of the results to their physician. LifeGuardTM is useful…

Read the full statement (134 words)

The LifeGuardTM is a guaiac-based test for the qualitative detection of occult blood in stool, which may indicate gastrointestinal disease. Patients can purchase the test without a prescription from stores or Internet distributors in order to perform testing at home. Users obtain their own stool samples by wiping onto the test device, then develop the tests, read the test results, and send a report of the results to their physician. LifeGuardTM is useful as an aid in the diagnosis of a number of gastrointestinal disorders and is used for colorectal cancer screening programs. The American Cancer Society recommends that at least three consecutive bowel movements be tested due to the irregularity of bleeding from some intestinal lesions. Therefore, the LifeGuardTM home test kit includes three test wipes for testing three closely spaced bowel movements.

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K022755: Lifeguard.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K022755

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026